A Feasibility Study of a Novel, Fully Remote Counseling and Sound Therapy Program for Hyperacusis
新型、完全远程咨询和听觉过敏声音治疗计划的可行性研究
基本信息
- 批准号:10651126
- 负责人:
- 金额:$ 36.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectAmericanAntidepressive AgentsAuditory PerceptionAuditory systemAwardClientClinicalClinical ManagementClinical ResearchClinical Trials DesignCognitive TherapyCommunicationComplementCounselingDataData CollectionDevicesDiseaseEducationEffectivenessEnsureEnvironmentEquipment and supply inventoriesExerciseExposure toFeasibility StudiesFocus GroupsFundingFutureGoalsGuidelinesHealth Services AccessibilityHearingHeterogeneityHourHyperacusisIndividualInstructionInterventionLoudnessLoudness PerceptionLow incomeMeasuresMental HealthMonitorMusicNatureNoiseOutcome MeasurePainParticipantPatientsPersonsPopulationProgram EffectivenessPsychiatric therapeutic procedurePsychoacousticsPublishingQuestionnairesRandomizedRandomized Controlled Clinical TrialsReactionRecommendationRelaxationReportingResearchResearch PersonnelRuralScienceSiteStudentsSymptomsTestingTrainingTreatment EffectivenessTreatment ProtocolsUnited States National Institutes of HealthWorkcollegecompare effectivenessdesigneffectiveness evaluationevidence baseexperienceimprovedinnovationnovelpatient engagementpatient orientedpatient populationprogramsrandomized, clinical trialsreaction rateremote administrationremote deliveryresearch studyresponsesoundsuccesstelecoachingtreatment effecttreatment programundergraduate researchundergraduate student
项目摘要
PROJECT SUMMARY/ABSTRACT
In line with the funding goals of the National Institutes of Health and the R15 AREA program, this application
proposes to investigate the feasibility of a remote counseling and sound therapy program for reducing reactions
to hyperacusis. Hyperacusis is a hearing condition causing one’s perception of sounds to be abnormally loud,
annoying, fearful, or painful. Clinical management of hyperacusis involves counseling to reduce negative
reactions to sounds and sound therapy to improve loudness perception. Despite these helpful approaches,
management of hyperacusis is restricted to highly specialized professionals located at large centers that are
inaccessible by most hyperacusis patients. Further, research evidence from controlled trials on the effectiveness
of these treatments for hyperacusis is lacking, involves only a small number of participants, and is limited to
specific approaches, such as cognitive behavioral therapy and low-level background noise. In response to these
needs, this research team developed Hyperacusis Activities Treatment (HAT), which includes two components:
counseling and sound therapy. Its effectiveness was demonstrated through data obtained from clinical focus
groups and small-scale research studies. There is additional potential for HAT to be remotely administered, thus
addressing the access-to-care issue currently facing many rural and low-income Americans who are suffering
from hyperacusis.
The aim of this proposed R15 project is to gather early clinical evidence for the effectiveness of HAT in relieving
hyperacusis using a novel, remote delivery approach. The innovative aspects of this project, including the remote
delivery and analysis of patient-centered interventions, will inform evidence-based clinical guidelines that are
currently lacking and produce more accessible solutions for hyperacusis management. The first aim will evaluate
feasibility of the remote counseling program, which includes weekly modules on relevant topics, homework, and
quizzes to keep participants engaged, and coaching to support participants. The second aim will compare the
effectiveness of two remotely-administered sound therapy options recommended for hyperacusis relief but that
are yet to be clinically evaluated—low-level background noise and successive approximations using bothersome
sounds. In Aim 1, each participant will complete 4 weeks of baseline testing (control) followed by 4 weeks of
counseling (treatment). In Aim 2, participants will be randomized into one of two sound therapy groups. At the
end of the project, the research team will have the early clinical evidence needed to support larger, multi-site,
future randomized clinical trials that will be designed to more fully evaluate the effectiveness of the remote
delivery of HAT’s counseling and customized sound therapy components to reduce reactions to hyperacusis. As
an R15 AREA award, the project will also have a significant impact through the research opportunities afforded
to student researchers who will be actively involved in the project, and on the research environment by enhancing
the PI’s work and advancing priorities of undergraduate research at Augustana College.
项目概要/摘要
根据美国国立卫生研究院和 R15 AREA 计划的资助目标,本申请
建议研究远程咨询和声音治疗计划以减少反应的可行性
听觉过敏是一种导致人对声音的感知异常响亮的听力状况,
听觉过敏的临床治疗包括减少负面影响的咨询。
尽管有这些有用的方法,但对声音的反应和声音疗法可以改善响度感知。
听力过敏的管理仅限于位于大型中心的高度专业化的专业人员,这些中心
大多数听觉过敏患者无法获得有关有效性的对照试验的研究证据。
这些针对听力过敏的治疗方法尚缺乏,仅涉及少数参与者,并且仅限于
针对这些问题的具体方法,例如认知行为疗法和低水平背景噪音。
根据需求,该研究团队开发了听觉过敏活动治疗(HAT),其中包括两个部分:
其有效性已通过临床焦点获得的数据得到证明。
HAT 还具有远程管理的潜力。
解决许多正在遭受苦难的农村和低收入美国人目前面临的获得医疗服务的问题
来自听觉过敏。
这个拟议的 R15 项目的目的是收集早期临床证据,证明 HAT 在缓解疼痛方面的有效性
hyperacusis 使用一种新颖的远程交付方法,该项目的创新方面包括远程。
以患者为中心的干预措施的实施和分析,将为基于证据的临床指南提供信息
目前缺乏并提供更易于使用的听力过敏管理解决方案。第一个目标是评估。
远程咨询计划的可行性,其中包括相关主题、作业和每周模块
第二个目标是通过测验来保持参与者的参与度,并通过辅导来支持参与者。
建议缓解听觉过敏的两种远程声音治疗方案的有效性,但
尚待临床评估——低水平背景噪声和使用烦人的逐次逼近
在目标 1 中,每个参与者将完成 4 周的基线测试(对照),然后是 4 周的测试。
在目标 2 中,参与者将被随机分为两个声音治疗组之一。
项目结束后,研究团队将获得支持更大、多地点、
未来的随机临床试验将旨在更全面地评估远程控制的有效性
提供 HAT 咨询和声音定制治疗组件,以减少听觉过敏反应。
R15 AREA 奖,该项目还将通过提供的研究机会产生重大影响
积极参与该项目的学生研究人员,以及通过加强研究环境
PI 的工作以及奥古斯塔纳学院本科生研究优先事项的推进。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ann Perreau其他文献
Ann Perreau的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
干旱内陆河高含沙河床对季节性河流入渗的影响机制
- 批准号:52379031
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
沿纬度梯度冠层结构多样性变化对森林生产力的影响
- 批准号:32371610
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
开放与二元结构下的中国工业化:对增长与分配的影响机制研究
- 批准号:72373005
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
基于MF和HPLC-ICP-MS监测蛋白冠形成与转化研究稀土掺杂上转换纳米颗粒对凝血平衡的影响机制
- 批准号:82360655
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
高寒草灌植被冠层与根系结构对三维土壤水分动态的影响研究
- 批准号:42301019
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 36.13万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 36.13万 - 项目类别:
Novel application of pharmaceutical AMD3100 to reduce risk in opioid use disorder: investigations of a causal relationship between CXCR4 expression and addiction vulnerability
药物 AMD3100 降低阿片类药物使用障碍风险的新应用:CXCR4 表达与成瘾脆弱性之间因果关系的研究
- 批准号:
10678062 - 财政年份:2023
- 资助金额:
$ 36.13万 - 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 36.13万 - 项目类别:
A role for cardiomyocyte pannexin 1 in non-ischemic heart failure
心肌细胞pannexin 1在非缺血性心力衰竭中的作用
- 批准号:
10680109 - 财政年份:2023
- 资助金额:
$ 36.13万 - 项目类别: